Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London
· Delayed Price · Currency is GBP · Price in USD 590.10
-6.80 (-1.14%)
At close: May 23, 2025
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of 46.06 billion as of May 27, 2025. Its market cap has decreased by -44.19% in one year.
Market Cap
46.06B
Enterprise Value
35.00B
Revenue
10.90B
Ranking
n/a
PE Ratio
13.23
Stock Price
590.10
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 96.12M to 46.06B, an increase of 47,819.52%. That is a compound annual growth rate of 20.66%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 161.82B |
| GSK plc | 57.83B |
| Haleon | 37.07B |
| Smith & Nephew | 9.30B |
| ConvaTec Group | 5.83B |
| Hikma Pharmaceuticals | 4.58B |
| HUTCHMED (China) | 1.78B |
| Genus | 1.33B |